| Literature DB >> 34612807 |
Qiulian Yang1, Yuan Gao1, Jian Ke1, Pau Loke Show2, Yuhui Ge1, Yanhua Liu1, Ruixin Guo1, Jianqiu Chen1.
Abstract
Antibiotics, as antimicrobial drugs, have been widely applied as human and veterinary medicines. Recently, many antibiotics have been detected in the environments due to their mass production, widespread use, but a lack of adequate treatment processes. The environmental occurrence of antibiotics has received worldwide attention due to their potential harm to the ecosystem and human health. Research status of antibiotics in the environment field is presented by bibliometrics. Herein, we provided a comprehensive overview on the following important issues: (1) occurrence of antibiotics in different environmental compartments, such as wastewater, surface water, and soil; (2) toxicity of antibiotics toward non-target organisms, including aquatic and terrestrial organisms; (3) current treatment technologies for the degradation and removal of antibiotics, including adsorption, hydrolysis, photodegradation and oxidation, and biodegradation. It was found that macrolides, fluoroquinolones, tetracyclines, and sulfonamides were most frequently detected in the environment. Compared to surface and groundwaters, wastewater contained a high concentration of antibiotic residues. Both antibiotics and their metabolites exhibited toxicity to non-target organisms, especially aquatic organisms (e.g., algae and fish). Fluoroquinolones, tetracyclines, and sulfonamides can be removed through abiotic process, such as adsorption, photodegradation, and oxidation. Fluoroquinolones and sulfonamides can directly undergo biodegradation. Further studies on the chronic effects of antibiotics at environmentally relevant concentrations on the ecosystem were urgently needed to fully understand the hazards of antibiotics and help the government to establish the permissible limits. Biodegradation is a promising technology; it has numerous advantages such as cost-effectiveness and environmental friendliness.Entities:
Keywords: Antibiotics; biodegradation; environmental occurrence; removal method; toxicity assessment
Mesh:
Substances:
Year: 2021 PMID: 34612807 PMCID: PMC8806427 DOI: 10.1080/21655979.2021.1974657
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 3.269
Figure 1.Annual number of publications (a) and cooccurrence network map of keywords (b) about researches on the environmental occurrence, toxicity, degradation, and removal of antibiotics during the last 10 years (from 2011 to 2021)
Figure 2.Top twenty active countries that conducted researches on the occurrence of antibiotics in the environment, and corresponding annual number of publications from 2011 to 2021
Concentration data of frequently detected antibiotics in different environmental compartments during 2011–2021
| Antibiotics | Aquatic environment (ng/L) | Solid matrices (ng/g dry matter) | Location | Refer-ence | |||||
|---|---|---|---|---|---|---|---|---|---|
| Influent of WWTPs | Effluent of WWTPs | Surface water (river/estuarine) | Groundwater | Seawater (harbor) | Sediment | Sewage sludge | |||
| Amoxicillin | 2,935–6,516 (3,746) | ND-1,129 | Singapore | [ | |||||
| ND-190 (20) | 5–21 (17) | Charmoise river (France) | [ | ||||||
| 200–4,600 | 900–1,600 | ND-300 | ND-43.8 | Kenyan | [ | ||||
| Erythromycin | 0.4–6.9 (3.9) | 1.5–24.6 (10.2) | Huangpu river (China) | [ | |||||
| 610 | 160 | ND-240 | ND | ND | Msunduzi River (South Africa) | [ | |||
| 111.4–403.3 (272.5) | 89.8–112 (98.2) | Singapore | [ | ||||||
| ND-1,492 (395) | 1–913 (293) | Charmoise river (France) | [ | ||||||
| 3–470 (118) | ND-350 (129) | ND-100 (56) | Sweden | [ | |||||
| 32.3–2,910 (973) | ND-28.9 (5.63) | Jianghan Plain (Central China) | [ | ||||||
| 2.50–8.16 | ND-17.66 | 1.16–6.88 | North Carolina (United States) | [ | |||||
| Roxithromycin | ND-227 (37.9) | ND-1.5 (0.38) | Bohai Sea (North China) | [ | |||||
| 25.2–65.2 | 7.82–58.0 | ND-80 | Guangdong (South China) | [ | |||||
| 0.2–2.2 (0.9) | 0.3–4.1 (1.9) | Huangpu river (China) | [ | ||||||
| ND-173 (38.37) | ND-3.18 (0.088) | Jianghan Plain (Central China) | [ | ||||||
| ND-1.75 (0.44) | ND | Yangtze River (China) | [ | ||||||
| Azithromycin | ND-88.0 (22.3) | ND-1.2 (0.14) | Bohai Sea (North China) | [ | |||||
| 1,537–2,951 (1,949) | 367.3–980 (469.5) | Singapore | [ | ||||||
| 221–2,819 | ND-43.2 | Leça River (Portugal) | [ | ||||||
| Clarithromycin | ND-32.9 (5.0) | ND-0.82 (0.19) | Bohai Sea (North China) | [ | |||||
| 30.8–126 | 5.16–86 | ND-69.5 | Guangdong (South China) | [ | |||||
| 1,201–1,854 (1,497) | 387.3–637.1 (531.7) | Singapore | [ | ||||||
| ND-32.1 (8.34) | ND-1.11 (0.02) | Jianghan Plain (Central China) | [ | ||||||
| ND-2.19 (0.26) | ND | Yangtze River (China) | [ | ||||||
| 76.6–269 | ND | Leça River (Portugal) | [ | ||||||
| Ciprofloxacin | ND-346 (101) | ND-66 (31) | Bohai Sea (North China) | [ | |||||
| 15.6–90.3 | 5.64–9.06 | 296–714 | Guangdong (South China) | [ | |||||
| 2,241–6,453 (3,496) | 321.3–524.1 (495.5) | Singapore | [ | ||||||
| 89–3,403 (817) | 5–1,523 (288) | 569 ± 418 | Charmoise river (France) | [ | |||||
| 83–1,406 (391) | ND-62 (38) | 1,600–11,000 (4,625) | Sweden | [ | |||||
| 4.46–96.0 (25.14) | 0.476–26.3 (6.23) | Jianghan Plain (central China) | [ | ||||||
| ND-0.94 (0.34) | 0.28–8.43 (1.24) | Yangtze River (China) | [ | ||||||
| ND-3,000 | 300–2,600 | ND-1,300 | ND-47.4 | Kenyan | [ | ||||
| ND-339 | ND | Leça River (Portugal) | [ | ||||||
| Ofloxacin | ND-45.4 (9.9) | ND-6.5 (0.24) | Bohai Sea (North China) | [ | |||||
| 30.3–1,010 | 47.4–179 | 1,500–5,800 | Guangdong (South China) | [ | |||||
| ND-28.5 (6.5) | ND-12.4 (4.1) | Huangpu river (China) | [ | ||||||
| 805–8,637 (4,312) | 100–2,888 (1,209) | 498 ± 261 | Charmoise river (France) | [ | |||||
| ND-45.3 (9.03) | ND-7.2 (0.47) | Jianghan Plain (Central China) | [ | ||||||
| ND-0.82 (0.32) | 0.29–84.17 (44.27) | Yangtze River (China) | [ | ||||||
| ND-120 | ND | Leça River (Portugal) | [ | ||||||
| Norfloxacin | ND-572 (118) | 7.5–103 (40) | Bohai Sea (North China) | [ | |||||
| 42.4–974 | 36.7–61 | 1,820–5,610 | Guangdong (South China) | [ | |||||
| 97–9,347 (1,542) | 14–1,261 (289) | 225 ± 70 | Charmoise river (France) | [ | |||||
| 9.57–277 (65.87) | 1.19–142 (23.75) | Jianghan Plain (Central China) | [ | ||||||
| ND-0.83 (0.32) | 0.15–0.83 (0.4) | Yangtze River (China) | [ | ||||||
| 900–2,800 | 500–2,900 | ND-2,200 | ND-26.6 | Kenyan | [ | ||||
| Enrofloxacin | ND-24.6 (10.6) | ND-7.6 (1.8) | Bohai Sea (North China) | [ | |||||
| ND-14.6 (2.8) | ND-8.9 (3.2) | Huangpu river (China) | [ | ||||||
| ND-636 (57) | ND | 11 ± 4.1 | Charmoise river (France) | [ | |||||
| ND-136 (35.56) | ND-30.3 (7.20) | Jianghan Plain (Central China) | [ | ||||||
| ND-0.89 (0.4) | 0.31–0.95 (0.58) | Yangtze River (China) | [ | ||||||
| Enoxacin | ND-508 (116) | ND-209 (62) | Bohai Sea (North China) | [ | |||||
| ND-1,634 (169) | ND-1,310 (134) | 31 ± 18 | Charmoise river (France) | [ | |||||
| Lomefloxacin | 3.22–25.5 | ND-8.59 | 25.1–440 | Guangdong (South China) | [ | ||||
| ND-16 (3) | 3.6–6.7 (5.5) | 5.3 ± 4.9 | Charmoise river (France) | [ | |||||
| ND-36.4 (9.98) | ND-10.7 (2.11) | Jianghan Plain (Central China) | [ | ||||||
| Tetracycline | 40.1–316 | 7.73–35.1 | 353–1,650 | Guangdong (South China) | [ | ||||
| ND-54.3 (4.2) | ND-21.7 (3.5) | Huangpu river (China) | [ | ||||||
| 1,240–12,340 (3,604) | 691.2–1,536 (766.4) | Singapore | [ | ||||||
| ND-238 (47) | ND-68 (16) | Charmoise river (France) | [ | ||||||
| ND-122 (36.25) | ND-38.9 (4.78) | Jianghan Plain (Central China) | [ | ||||||
| Chlortetracycline | 7.46–35.7 | ND | 34.6–455 | Guangdong (South China) | [ | ||||
| ND-46.7 (3.6) | ND-6.3 (2.4) | Huangpu river (China) | [ | ||||||
| 2,333–15,911 (6,434) | 1,472–1,986 (1,757) | Singapore | [ | ||||||
| 12.3–109 (33) | 0.71–59.6 (6.16) | Jianghan Plain, (Central China) | [ | ||||||
| ND-0.95 (0.55) | ND-0.95 (0.39) | Yangtze River (China) | [ | ||||||
| Oxytetracycline | 79.1–560 | 10.8–17.6 | 417–1,680 | Guangdong (South China) | [ | ||||
| ND-219.8 (78.3) | 0.6–18.6 (6.9) | Huangpu river (China) | [ | ||||||
| 1,629–30,049 (4,887) | 839.8–2,014 (1,469) | Singapore | [ | ||||||
| ND-63.1(24.79) | ND-24.3 (3.18) | Jianghan Plain (Central China) | [ | ||||||
| ND-0.97 (0.37) | 0.16–0.93 (0.41) | Yangtze River (China) | [ | ||||||
| Doxycycline | ND-23.0 | ND | 103–232 | Guangdong (South China) | [ | ||||
| ND-112.3 (11.3) | ND-21.3 (7.0) | Huangpu river (China) | [ | ||||||
| ND-2,700 | 400–1,500 | ND-700 | ND-32.2 | Kenyan | [ | ||||
| Minocycline | 730.9–3,808 (1,233) | ND | Singapore | [ | |||||
| Sulfamethoxazole | 0.36–527 (62.8) | 1.5–82 (19) | Bohai Sea (North China) | [ | |||||
| 216–239 | 65.2–106 | ND-10.0 | Guangdong (South China) | [ | |||||
| 2.2–764.9 (259.6) | 0.05–0.6 (0.2) | Huangpu river (China) | [ | ||||||
| 34,500 | ND | ND-5,320 | ND | ND | Msunduzi River (South Africa) | [ | |||
| 893.4–1,389 (1,172) | 301.5–463.4 (311.3) | Singapore | [ | ||||||
| 407–12,848 (3,375) | 41–3,066 (1,119) | 7.2 ± 2.1 | Charmoise river (France) | [ | |||||
| 1.92–30.2 (13.67) | ND-7.29 (1.01) | Jianghan Plain (Central China) | [ | ||||||
| 374.3–1,309.5 (842.4) | 15–218 (130) | 47.8–251.4 (106) | Bolivia | [ | |||||
| 0.43–7.95 (3.84) | 0.14–2.04 (1.39) | Yangtze River (China) | [ | ||||||
| 5.97–14.54 | 1.01–54.04 | 2.77–6.89 | North Carolina (United States) | [ | |||||
| Sulfadiazine | ND-18.7 (1.7) | ND-0.43 (0.02) | Bohai Sea (North China) | [ | |||||
| 15.2–40.1 | 1.14–9.67 | ND | Guangdong (South China) | [ | |||||
| 4.9–112.5 (53.6) | 0.07–0.71 (0.4) | Huangpu river (China) | [ | ||||||
| ND-16.7 (5.16) | ND-2.87 (0.55) | Jianghan Plain (Central China) | [ | ||||||
| ND-0.46 (0.23) | ND-0.57 (0.1) | Yangtze River (China) | [ | ||||||
| Sulfamethazine | 12.8–131 | 7.3–23.3 | ND-3.83 | Guangdong (South China) | [ | ||||
| 19.9–389.4 (188.9) | 0.2–2.7 (1.2) | Huangpu river (China) | [ | ||||||
| ND | ND | ND-1,090 | ND | ND | Msunduzi River (South Africa) | [ | |||
| 449.9–1,814 (802.8) | 73–260.8 (135.9) | Singapore | [ | ||||||
| ND-27.3 (5.36) | ND-15.9 (0.50) | Jianghan Plain (Central China) | [ | ||||||
| 0.24–0.79 (0.48) | ND-0.27 (0.16) | Yangtze River (China) | [ | ||||||
| Sulfapyridine | 29.8–121 | 7.08–24.1 | ND-2.31 | Guangdong (South China) | [ | ||||
| ND-103.1 (24.1) | ND-6.6 (1.7) | Huangpu river (China) | [ | ||||||
| Trimethoprim | ND-13,600 (1,133) | 1.3–330 (53) | Bohai Sea (North China) | [ | |||||
| 72.3–162 | 31.1–64 | 3.57–10.7 | Guangdong (South China) | [ | |||||
| ND | ND | ND-290 | ND- 87.55 | ND | Msunduzi River (South Africa) | [ | |||
| 197.6–251.2 (235.5) | 124.9–178.6 (151.6) | Singapore | [ | ||||||
| ND-5,316 (1,568) | 1–1,573 (442) | 52 ± 27 | Charmoise river (France) | [ | |||||
| 51–340 (115) | 10–130 (61) | ND-58 (42) | Sweden | [ | |||||
| 271–336.5 (304) | 46–312 (159) | 108–200.2 (154.2) | Bolivia | [ | |||||
| 0.24–0.96 (0.73) | ND-0.99 (0.23) | Yangtze River (China) | [ | ||||||
| 100–5,600 | 100–500 | ND-200 | ND-13.3 | Kenyan | [ | ||||
| ND-110 | ND | Leça River (Portugal) | [ | ||||||
| AMX penilloic acid | 150 | 30 | Israel | [ | |||||
| AMX 2ʹ,5ʹ- diketopiperazine | 500 | Israel | |||||||
| Erythromycin | 771–942 | 83.9–695 | 29.3–147 | Guangdong (South China) | [ | ||||
| 299.3–737 (652.1) | 194.5–381 (272.6) | Singapore | [ | ||||||
| ND-30 (4.67) | ND-6.78 (1.2) | Yangtze River (China) | [ | ||||||
| D-ciprofloxacin | ND-127 (27) | 7–71 (16) | 22 ± 11 | Charmoise river (France) | [ | ||||
| 4-epidemeclocycline | 17–1,159 | Canada | [ | ||||||
| Isochlortetracycline | 192–3,256 | Canada | |||||||
| N-acetyl SMX | 18–1,245 (410) | 4–406 (124) | Charmoise river (France) | [ | |||||
| ND-290.3 | ND | Bolivia | [ | ||||||
| SMX-N1-glucuronide | ND-233.7 | ND | Bolivia | ||||||
Note: WWTPs: wastewater treatment plants; max: maximum concentration; med: median concentration; A-B (C): range (mean/median); (A ± B): (mean±SD); ND: no detected or below detection limit; AMX: amoxicillin; SMX: sulfamethoxazole; D-ciprofloxacin: desethylene ciprofloxacin
Toxicity data of antibiotics to non-target aquatic organisms
| Antibiotics | Taxonomic group | Species | Endpoint | Value (mg/L) | Reference |
|---|---|---|---|---|---|
| Amoxicillin | Cyanobacteria | 72 h-EC50 (bioluminescence) | 56.3 | [ | |
| Algae | 72 h-EC50 (growth) | >1500 | |||
| 72 h-EC50 (growth) | >2000 | [ | |||
| Ampicillin | Algae | 72 h-EC50 (growth) | >2000 | ||
| Cephalothin | Algae | 72 h-EC50 (growth) | >600 | ||
| Erythromycin | Cyanobacteria | 72 h-EC50 (bioluminescence) | 0.022 | [ | |
| Algae | 72 h-EC50 (growth) | 0.35 | |||
| Tylosin | Cyanobacteria | 4d-EC50 (growth) | 0.098 | [ | |
| 4d-EC50 (growth) | 0.096 | ||||
| Algae | 4d-EC50 (growth) | 4.41 | |||
| 4d-EC50 (growth) | 13 | ||||
| 4d-EC50 (growth) | >86.57 | ||||
| 4d-EC50 (growth) | 1.41 | ||||
| 4d-EC50 (growth) | 6.08 | ||||
| (4–5d) IC50 (growth) | 0.27 | [ | |||
| (4–5d) IC50 (growth) | 0.99 | ||||
| Clarithromycin | Cyanobacteria | 72 h-EC50 (growth) | 0.0121 | [ | |
| Algae | 72 h-EC50 (growth) | 0.0371 | |||
| 72 h-NOEC | 0.025 | ||||
| Duckweed | 7d-EC50 (growth) | >1.9 | |||
| 7d-EC50 (growth) | 0.8 | ||||
| Crustaceans | 48 h-EC50 (immobilization) | >2 | |||
| 21d-NOEC (reproduction) | >2.1 | ||||
| Fish | 48 h-EC50 (lethality) | >2 | |||
| Ciprofloxacin | Marine bacteria | periphytic bacteria | 72 h-EC50 (growth) | 0.16 | [ |
| 72 h-NOEC (growth) | 0.0086 | ||||
| 72 h-EC50 (growth) | 11.3 | [ | |||
| Algae | (4–5d) IC50 (growth) | 55.43 | [ | ||
| (4–5d) IC50 (growth) | 72.12 | ||||
| 72 h-IC50 (growth) | 9.23 | [ | |||
| 96 h-IC50 (growth) | 29.09 | ||||
| 72 h-NOEC (growth) | <20 | ||||
| 72-LOEC (growth) | 20 | ||||
| 96 h-EC50 (growth) | 65 | [ | |||
| Levofloxacin | Cyanobacteria | 72 h-EC50 (bioluminescence) | 4.8 | [ | |
| Algae | 72 h-EC50 (growth) | >120 | |||
| Norfloxacin | Cyanobacteria | 72 h-EC50 (bioluminescence) | 5.6 | ||
| Algae | 72 h-EC50 (growth) | >80 | |||
| Tetracycline | Cyanobacteria | 72 h-EC50 (bioluminescence) | 6.2 | [ | |
| Algae | 72 h-EC50 (growth) | 3.31 | |||
| Ciliates | 24 h-EC50 (growth) | 94.4 | [ | ||
| 24 h-EC50 (growth) | 40.1 | ||||
| Oxytetracycline | Algae | 96 h-IC50 (growth) | 17.25 | [ | |
| Sulfamonomethoxine | Algae | 72 h-EC50 (growth) | 5.9 | [ | |
| 72 h-EC50 (growth) | 9.7 | [ | |||
| Crustaceans | 48 h-LC50 (survival) | 48 | |||
| 21d-EC50 (reproduction) | 14.9 | ||||
| 48 h-LC50 (survival) | 283 | ||||
| 21d-EC50 (reproduction) | 41.9 | ||||
| Fish | 96 h-LC50 (survival) | >1000 | |||
| Sulfamethazine | Marine bacteria | 30 min-EC50 | >100 | [ | |
| 4h-EC50 | >139 | ||||
| Algae | 24 h-EC50 (growth) | 19.52 | |||
| Duckweed | 7d-EC50 (growth) | 1.74 | |||
| Sulfadiazine | Marine bacteria | 30 min-EC50 | >25 | ||
| 4h-EC50 | >125 | ||||
| Algae | 24 h-EC50 (growth) | 2.22 | |||
| Duckweed | 7d-EC50 (growth) | 0.07 | |||
| Sulfamerazine | Marine bacteria | 30 min-EC50 | >50 | ||
| 4 h-EC50 | >132 | ||||
| Algae | 24 h-EC50 (growth) | 11.90 | |||
| Duckweed | 7d-EC50 (growth) | 0.68 | |||
| Sulfamethoxazole | Marine bacteria | 30 min-EC50 | >100 | ||
| periphytic bacteria | 72 h-EC50 (growth) | 0.27 | [ | ||
| Algae | 24 h-EC50 (growth) | 1.54 | [ | ||
| Duckweed | 7d-EC50 (growth) | 0.21 | |||
| Sulfathiazole | Marine bacteria | 30 min-EC50 | >50 | ||
| Algae | 24 h-EC50 (growth) | 13.10 | |||
| Duckweed | 7d-EC50 (growth) | 4.89 | |||
| Sulfapyridine | Marine bacteria | 30 min-EC50 | >50 | ||
| Algae | 24 h-EC50 (growth) | 5.28 | |||
| Duckweed | 7d-EC50 (growth) | 0.46 | |||
| Sulfamethoxypyridazine | Marine bacteria | 30 min-EC50 | >100 | ||
| Algae | 24 h-EC50 (growth) | 3.82 | |||
| Duckweed | 7d-EC50 (growth) | 1.51 | |||
| Trimethoprim | Cyanobacteria | 4d-EC50 (growth) | 91.68 | [ | |
| 4d-EC50 (growth) | >100 | ||||
| Algae | 4d-EC50 (growth) | >63.37 | |||
| 4d-EC50 (growth) | >100 | ||||
| 4d-EC50 (growth) | >100 | ||||
| 4d-EC50 (growth) | 2.14 | ||||
| 4d-EC50 (growth) | 21.66 | ||||
| Lincomycin | Cyanobacteria | 4d-EC50 (growth) | 0.058 | [ | |
| 4d-EC50 (growth) | 0.042 | ||||
| Algae | 4d-EC50 (growth) | 3.26 | |||
| 4d-EC50 (growth) | 7.12 | ||||
| 4d-EC50 (growth) | >100 | ||||
| 4d-EC50 (growth) | >100 | ||||
| 4d-EC50 (growth) | >100 | ||||
| (4–5d) IC50 (growth) | 14.16 | [ | |||
| (4–5d) IC50 (growth) | 11.08 | ||||
| Chloramphenicol | Algae | 96 h-IC50 (growth) | 11.16 | [ | |
| Florphenicol | Algae | 96 h-IC50 (growth) | 9.03 | ||
| Gentamycin | Algae | 72 h-EC50 (growth) | 19.2 | [ | |
| Vancomycin | Algae | 72 h-EC50 (growth) | 724 | ||
| 14-hydroxy | Cyanobacteria | 72 h-EC50 (growth) | 0.0272 | [ | |
| 72 h-NOEC | 0.0027 | ||||
| Algae | 72 h-EC50 (growth) | 0.0463 | |||
| 72 h-NOEC | 0.02 | ||||
| Crustaceans | 48 h-EC50 (immobilization) | >2 | |||
| 21d-NOEC (reproduction) | >0.85 | ||||
| Fish | 48 h-EC50 (lethality) | >2 | |||
| N-desmethyl- clarithromycin | Cyanobacteria | 72 h-EC50 (growth) | 0.134 | ||
| Algae | 72 h-EC50 (growth) | 0.575 | |||
| 72 h-NOEC | 0.115 | ||||
| Crustaceans | 48 h-EC50 (immobilization) | >0.7 | |||
| 21d-NOEC (reproduction) | 0.15 | ||||
| 21d-LOEC (reproduction) | 0.75 | ||||
| Fish | 48 h-EC50 (lethality) | >2 | |||
Note: Pseudokirchneriella subcapitata: P. subcapitata; Anabaena flos-aquae: A. flos-aquae; Synechococcus leopoliensis: S. leopoliensis; Cylindrotheca closterium: C. closterium; Navicula ramosissima: N. ramosissima; Desmodesmus subspicatus: D. subspicatus; Phaeodactylum tricornutum: P. tricornutum; Microcystis aeruginosa: M. aeruginosa; Chlamydomonas mexicana: C. mexicana; Arthrobacter globiformis: A. globiformis; Scenedesmus vacuolatus: S. vacuolatus; EC50: median effective concentration; LC50: median lethal concentration; IC50: median inhibition concentration; NOEC: no-observed-effect concentration; LOEC: lowest observed effect concentration
Identified transformation of antibiotics
| Experimental | ||||||||
|---|---|---|---|---|---|---|---|---|
| Amoxicillin | Hydrolysis | C15H22N3O4S | 340.1316 | (5 R)-AMX penilloic acid * | β-lactam ring cleavage, decarboxylation | [ | ||
| C15H22N3O4S | 340.1337 | (5S)-AMX penilloic acid * | epimerization | |||||
| C16H20N3O5S | 366.1131 | (5 R)-AMX 2ʹ, 5ʹ- diketopiperazine* | β-lactam ring cleavage, decarboxylation, internal rearrangement | |||||
| C16H20N3O5S | 366.1124 | (5S)-AMX 2ʹ, 5ʹ- diketopiperazine* | epimerization | |||||
| C17H24N3O6S | 398.1383 | amoxicilloic acid methyl ester | β-lactam ring cleavage | |||||
| Hydrolysis | 189 | phenol hydroxypyrazine* | a series of AMX-degradation | [ | ||||
| 384 | AMX penicilloic acid * | |||||||
| Ampicillin | Hydrolysis | 173.1 | amide cleavage, ecarboxylation | [ | ||||
| 410.1 | β-lactam cleavage | |||||||
| Hydrolysis (pH7/9 & 60°C) | 368.1 | β-lactam cleavage | ||||||
| 368.1 | β-lactam cleavage, pimerization | |||||||
| 324.1 | β-lactam cleavage, decarboxylation | |||||||
| Cefalotin | Hydrolysis | 311.1 | ester hydrolysis, decarboxylation | [ | ||||
| 333.1 | β-lactam cleavage, | |||||||
| Hydrolysis | 247.0 | β-lactam hydration, | ||||||
| Hydrolysis | 377.1 | β-lactam hydration, | ||||||
| 238.1 | β-lactam hydration, | |||||||
| 224.1 | β-lactam hydration, | |||||||
| Cefoxitin | Hydrolysis (pH4/7 & 60°C) | 407.0 | carbamate hydrolysis | [ | ||||
| 297.0 | side chain cleavage, decarboxylation | |||||||
| 389.0 | carbamate hydrolysis, β-lactam hydration | |||||||
| Hydrolysis (pH7/9 & 60°C) | 221.1 | β-lactam cleavage, carbamate and amide hydrolysis | ||||||
| 251.1 | β-lactam hydration, | |||||||
| Hydrolysis (pH4/7/9 & 60°C) | 268.1 | β-lactam hydration, carbamate hydrolysis, | ||||||
| 254.1 | demethylation | |||||||
| 236.1 | side chain cleavage | |||||||
| Cephradine | Photolysis (Simulated sunlight) | 306 | decarboxylation | [ | ||||
| 211 | β-lactam cleavage | |||||||
| Cephalexin | Photolysis (Simulated sunlight) | 304 | decarboxylation | [ | ||||
| 209 | β-lactam cleavage | |||||||
| Cephapirin | Photolysis (Simulated sunlight) | 126 | [ | |||||
| 380 | decarboxylation | |||||||
| Clarithromycin | Biodegradation ( | C38H70NO14 | 764.48 | 14-hydroxy-CTM | hydroxylation | [ | ||
| C37H68NO13 | 734.47 | N-desmethyl-CTM | desmethyl | |||||
| C30H56NO11 | 606.38 | 14-hydroxy-descladinosyl-CTM | cleavage of the glycosidic bond, L-cladinose moiety loss | |||||
| C30H56NO10 | 590.39 | descladinosyl-CTM | cleavage of the glycosidic bond, L-cladinose moiety loss | |||||
| Erythromycin | UV photolysis (254 nm) | C34H64NO12 | 678.4429 | cladinose ring cleavage | [ | |||
| C29H54NO12 | 608.3647 | cladinose ring cleavage | ||||||
| C29H52NO11 | 590.3542 | cladinose ring cleavage | ||||||
| C23H41O7 | 429.2825 | formate adduct | ||||||
| Biodegradation ( | 575.37 | 3-depyranosyloxy erythromycin | depyranosyloxy | [ | ||||
| 418.26 | 7,12-dyhydroxy-6-deoxyerythronolide | |||||||
| 386.27 | 6-deoxyerythronolide | |||||||
| 75.04 | propionaldehyde | |||||||
| Roxithromycin | UV photolysis (254 nm) | C37H68NO13 | 734.4691 | erythromycin | [ | |||
| C29H54NO10 | 576.3748 | cladinose moiety loss | ||||||
| Tylosin | Hydrolysis | 936.6 | cyclic ester hydrolysis, alcohol formation | [ | ||||
| 934.5 | cyclic ester hydrolysis | |||||||
| 916.5 | tylosin isomer | |||||||
| Hydrolysis | 772.4 | mycarose loss | ||||||
| Spiramycin | Hydrolysis (pH7/9 & 60°C) | 861.5 | cyclic ester hydrolysis | [ | ||||
| Hydrolysis | 699.4 | mycarose sugar loss | ||||||
| 558.3 | mycarose and forosamine loss | |||||||
| Enrofloxacin | Photolysis (pH 7–8 & Simulated sunlight) | C19H23N3O4 | 358.1769 | hydroxyl group substitutes F atom | [ | |||
| C17H21N3O3 | 316.1660 | defluorination, piperazine ring cleavage | ||||||
| C17H18FN3O3 | 332.1415 | ciprofloxacin | desethyl | |||||
| C19H23N3O5 | 374.1713 | hydroxylation | ||||||
| Ciprofloxacin | Photolysis | 330 | 1-cyclopropyl-6-hydroxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3- carboxyl acid | hydroxyl group substitutes F atom | [ | |||
| 346 | 1-cyclopropyl-2,6-dihydroxy-4-oxo-7-(piperazin–yl) 1,4-dihydroquin oline-3-carboxyl acid | di-hydroxylation | ||||||
| 316 | 7-[(2-ethylamino)(formyl)amino]-1-cyclopropyl-4-oxo-1,4-dihydroquinoline-3- carboxyl acid | defluorination, piperazine ring cleavage | ||||||
| 288 | 1-cyclopropyl-6-fluoro-7- (piperazin-1-yl) quinolin- 4(1H)-one | decarboxylation | ||||||
| UV photolysis (254 nm) | C17H19FN3O4 | 348.1354 | mono-hydroxylation | [ | ||||
| C17H20FN3O5 | 346.1394 | di-hydroxylation | ||||||
| C17H20FN3O4 | 330.1444 | hydroxyl group substitutes F atom | ||||||
| C16H18FN3O4 | 316.1287 | piperazinyl ring cleavage | ||||||
| C15H18FN3O2 | 272.1391 | piperazinyl ring cleavage, decarboxylation | ||||||
| C15H18FN3O3 | 288.134 | |||||||
| C17H20FN3O3 | 314.1499 | defluorination | ||||||
| C13H13FN2O3 | 245.0917 | piperazinyl ring cleavage | ||||||
| Biodegradation (mixture of F11, FP1 and S2) | C13H12FN2O3 | 262.90 | piperazine ring cleavage | [ | ||||
| C15H17FN3O3 | 305.93 | C2H2 loss | ||||||
| C17H19FN3O4 | 347.90 | hydroxylation | ||||||
| Norfloxacin | UV Photolysis (pH 2–12) | C16H12FN2O7 | 363.0631 | oxidation | [ | |||
| C14H17FN3O3 | 294.1237 | piperazine ring cleavage | ||||||
| C14H16FN2O3 | 279.1132 | |||||||
| C12H12FN2O3 | 251.0827 | |||||||
| C16H15FN3O5 | 348.1013 | oxidation | ||||||
| Biodegradation (mixture of F11, FP1 and S2) | C16H19FN3O4 | 335.90 | piperazinyl ring cleavage | [ | ||||
| C14H17FN3O3 | 293.93 | piperazinyl ring cleavage (C2H2 loss) | ||||||
| C16H20N3O4 | 317.93 | piperazine ring cleavage, amide formation, defluorination | ||||||
| Ofloxacin | Sorption on TiO2 surfaces | 227.0 | piperazinyl ring loss, | [ | ||||
| 242.9 | piperazinyl ring loss, decarboxylation, hydroxylation | |||||||
| 259.0 | piperazinyl ring loss, decarboxylation, hydroxylation | |||||||
| Desorption from TiO2 surfaces | 159.0 | |||||||
| 319.9 | demethylation | |||||||
| 348.1 | demethylation | |||||||
| Biodegradation (mixture of F11, FP1 and S2) | C17H19FN3O4 | 348.00 | demethylation | [ | ||||
| C16H19FN3O4 | 336.10 | decarboxylation, hydroxylation | ||||||
| Moxifloxacin | Biodegradation (mixture of F11, FP1 and S2) | C14H14FN2O4 | 292.90 | (4aS,7aS)-octahydro-6 H- pyrrolo [3,4-b] pyridine-6-yl group oxidation | [ | |||
| C21H23FN3O5 | 415.92 | |||||||
| Oxytetracycline | UV-visible light photolysis | 416.5 | analogue of 4-dedimethylaminotetrcycline (DTC) | dedimethylamino | [ | |||
| Chlortetracycline | Biodegradation ( | C18H20O6 | 332.1 | Cl atom loss, -N(CH3)2 loss | [ | |||
| C22H23N2O8 | 445.1 | tetracycline | Cl atom loss | |||||
| C21H21ClN2O8 | 465.0 | 6-demethyl- chlortetracycline | methyl group loss from the -N(CH3)2 | |||||
| 511 | di-hydroxylation | |||||||
| Sulfadiazine | Biodegradation ( | 96 | 2-Aminopyrimidine* | [ | ||||
| 112 | 2-amino-4- hydroxypyrimidine * | hydroxylation | ||||||
| 128 | 2-amino-4, 6-dihydroxypyrimidine* | di-hydroxylation | ||||||
| 173 | Sulfanilamide* | |||||||
| 87 | ||||||||
| 176 | pyrimidin-2ylsulfamic acid | |||||||
| aniline acetylation | ||||||||
| Sulfanilamide | Biodegradation | 108.1 | [ | |||||
| 155.8 | benzene sulfonamide | |||||||
| 190.4 | hydroxylamine benzene sulfonamide | |||||||
| Sulfamethoxazole | UV photolysis (350 nm) | C10H14N3O | 192.1131 | sulfur dioxide loss | [ | |||
| Biodegradation | C12H13N3O4S | 294.0554 | N4-acetyl -SMX* | acetylation | [ | |||
| C12H13N3O4S | 296.0696 | N1-acetyl – SMX | acetylation | |||||
| Trimethoprim | Biodegradation | C14H18N4O4 | 307.1399 | hydroxylation | [ | |||
| Sulfamethoxypyridazine | UV photolysis | C11H12N4O4S | 297.1 | hydroxylation | [ | |||
| C11H11N4O4S | 295.1 | N-oxidation | ||||||
| Chloramphenicol | Hydrolysis (pH4/7/9 & 60°C) | 213.1 | amide hydrolysis | [ | ||||
| Florfenicol | Hydrolysis (pH4/7/9 & 60°C) | 356.0 | alkyl fluorine hydrolysis | [ | ||||
| Hydrolysis | 288.1 | dechlorination and alkyl fluorine hydrolysis | ||||||
| Hydrolysis (pH4 & 60°C) | 248.1 | amide hydrolysis | ||||||
| Hydrolysis (pH7/9 & 60°C) | 272.1 | alkyl fluorine hydrolysis, dechlorination, demethylation | ||||||
| 246.1 | Amide and alkyl fluorine hydrolysis | |||||||
| Clindamycine | Biodegradation | C18H33ClN2O6S | 441.1817 | clindamycin sulfoxide | [ | |||
| C18H33ClN2O7S | 457.1784 | Hydroxy clindamycin sulfoxide | ||||||
| C17H31ClN2O5S | 411.1713 | S-demethyl clindamycin | ||||||
| C17H31ClN2O5S | 411.1720 | N-demethyl clindamycin |
*Indicates exact structure.
Figure 3.Proposed degradation pathways for SMX and its metabolites. (a) Under simulated solar (source [148]:); (b) under UV/CoFe2O4/TiO2 (source [150]:)